PUBLICACIÓN

ACCEDER A LA PUBLICACIÓN: Scopus Orcid Dialnet

Neuroscience (miscellaneous) (Q2)

JCR: 3.332

SJR: 0.999

CITAS

DOI

EID

ISSN

EISSN

ISBN

BIBTEX

AUTORES DE LA UEX

OTRAS PUBLICACIONES DE INTERÉS

Postanoxic Myoclonus And Clonazepam
Correlación Entre Respuesta Metabólica Determinada Con [18f]fdg Pet/tc Y Respuesta Histológica Tras Tratamiento Neoadyuvante Y Cirugía En Pacientes Con Cáncer De Esófago
Safinamide In Clinical Practice: A Spanish Multicenter Cohort Study
Correlación Entre Respuesta Metabólica Determinada Con [18f]fdg Pet/tc Y Respuesta Histológica Tras Tratamiento Neoadyuvante Y Cirugía En Pacientes Con Cáncer De Esófago
Safinamide In Clinical Practice: A Spanish Multicenter Cohort Study
Nuevos Fármacos Para Los Síntomas No Motores En La Enfermedad De Parkinson
Safinamide In Clinical Practice: A Spanish Multicenter Cohort Study
Nuevos Fármacos Para Los Síntomas No Motores En La Enfermedad De Parkinson
Clinical Application Of Roll Technique In Non- Breast Diseases. Complementary Use After Pet-Ct Study
Nuevos Fármacos Para Los Síntomas No Motores En La Enfermedad De Parkinson
Clinical Application Of Roll Technique In Non- Breast Diseases. Complementary Use After Pet-Ct Study
Suicidal Ideation In A European Huntington's Disease Population
Clinical Application Of Roll Technique In Non- Breast Diseases. Complementary Use After Pet-Ct Study
Suicidal Ideation In A European Huntington's Disease Population
Tratamiento De Síntomas No Motores En La Enfermedad De Parkinson
Suicidal Ideation In A European Huntington's Disease Population
Tratamiento De Síntomas No Motores En La Enfermedad De Parkinson
A New Scarb2 Mutation In A Patient With Progressive Myoclonus Ataxia Without Renal Failure
Tratamiento De Síntomas No Motores En La Enfermedad De Parkinson
A New Scarb2 Mutation In A Patient With Progressive Myoclonus Ataxia Without Renal Failure
Levodopa In The Treatment Of Parkinson's Disease: Myths And Realties
A New Scarb2 Mutation In A Patient With Progressive Myoclonus Ataxia Without Renal Failure
Levodopa In The Treatment Of Parkinson's Disease: Myths And Realties
Hereditary Ataxia And Cerebellum Disease
Levodopa In The Treatment Of Parkinson's Disease: Myths And Realties
Hereditary Ataxia And Cerebellum Disease
Genetic Screening For The Lrrk2, G2019s And R1441 Codon Mutations In Parkinson's Disease Patients From Extremadura, Spain
Hereditary Ataxia And Cerebellum Disease
Genetic Screening For The Lrrk2, G2019s And R1441 Codon Mutations In Parkinson's Disease Patients From Extremadura, Spain
Tratamiento De La Enfermedad De Parkinson. ¿podemos Modificar El Curso De La Enfermedad?
Genetic Screening For The Lrrk2, G2019s And R1441 Codon Mutations In Parkinson's Disease Patients From Extremadura, Spain
Tratamiento De La Enfermedad De Parkinson. ¿podemos Modificar El Curso De La Enfermedad?
Treatment Of Parkinson's Disease. Can We Alter The Course Of The Disease?
Tratamiento De La Enfermedad De Parkinson. ¿podemos Modificar El Curso De La Enfermedad?
Treatment Of Parkinson's Disease. Can We Alter The Course Of The Disease?
Negative Predictive Value Of Spect With I123 Ioflupane In Movement Disorders (Reply)
Treatment Of Parkinson's Disease. Can We Alter The Course Of The Disease?
Negative Predictive Value Of Spect With I123 Ioflupane In Movement Disorders (Reply)
Negative Predictive Value Of 123i Ioflupane Spect In Movement Disorders
Negative Predictive Value Of Spect With I123 Ioflupane In Movement Disorders (Reply)
Negative Predictive Value Of 123i Ioflupane Spect In Movement Disorders
Negative Predictive Value Of123i Ioflupane Spect In Movement Disorders | Valor Predictivo Negativo Del Spect Con Ioflupano123i En Los Trastornos Del Movimiento
Negative Predictive Value Of 123i Ioflupane Spect In Movement Disorders
Negative Predictive Value Of123i Ioflupane Spect In Movement Disorders | Valor Predictivo Negativo Del Spect Con Ioflupano123i En Los Trastornos Del Movimiento
A Longitudinal Study Of Patients With Parkinson's Disease (Elep): Aims And Methodology
Negative Predictive Value Of123i Ioflupane Spect In Movement Disorders | Valor Predictivo Negativo Del Spect Con Ioflupano123i En Los Trastornos Del Movimiento
A Longitudinal Study Of Patients With Parkinson's Disease (Elep): Aims And Methodology
Paralysis Of The Nucleus Of The Third Cranial Nerve Secondary To A Mesencephalic Haematoma
A Longitudinal Study Of Patients With Parkinson's Disease (Elep): Aims And Methodology
Paralysis Of The Nucleus Of The Third Cranial Nerve Secondary To A Mesencephalic Haematoma
Sixty-Seven-Year-Old Male With Subacute Progressive Ataxia And Extense Involvement Of The Lower Cranial Nerves
Paralysis Of The Nucleus Of The Third Cranial Nerve Secondary To A Mesencephalic Haematoma
Sixty-Seven-Year-Old Male With Subacute Progressive Ataxia And Extense Involvement Of The Lower Cranial Nerves
Transient Coma Due To Vertebral-Basilar Stroke, Naloxone Reversed? [8]
Sixty-Seven-Year-Old Male With Subacute Progressive Ataxia And Extense Involvement Of The Lower Cranial Nerves
Transient Coma Due To Vertebral-Basilar Stroke, Naloxone Reversed? [8]
Disorder Of Vertical Conjugate Gaze Secondary To A Bilateral Thalamic Infarct Which Occurred During An Attack Of Migraine
Transient Coma Due To Vertebral-Basilar Stroke, Naloxone Reversed? [8]
Disorder Of Vertical Conjugate Gaze Secondary To A Bilateral Thalamic Infarct Which Occurred During An Attack Of Migraine
Diagnostic Value Of Magnetic Resonance In Neurosyphilis
Disorder Of Vertical Conjugate Gaze Secondary To A Bilateral Thalamic Infarct Which Occurred During An Attack Of Migraine
Diagnostic Value Of Magnetic Resonance In Neurosyphilis
Postanoxic Myoclonus And Clonazepam
Diagnostic Value Of Magnetic Resonance In Neurosyphilis
Postanoxic Myoclonus And Clonazepam
Correlación Entre Respuesta Metabólica Determinada Con [18f]fdg Pet/tc Y Respuesta Histológica Tras Tratamiento Neoadyuvante Y Cirugía En Pacientes Con Cáncer De Esófago
WEB ACCESIBLE